Published in Nurs Times on December 23, 2005
Evaluation of a patient-initiated review system in rheumatoid arthritis: an implementation trial protocol. BMC Musculoskelet Disord (2012) 0.82
Patient involvement in rheumatology outpatient service design and delivery: a case study. Health Expect (2016) 0.75
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum (2011) 6.28
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis (2011) 4.15
Persistent pain after joint replacement: prevalence, sensory qualities, and postoperative determinants. Pain (2011) 2.81
Outcomes from the Patient Perspective Workshop at OMERACT 6. J Rheumatol (2003) 2.20
Patients and professionals as research partners: challenges, practicalities, and benefits. Arthritis Rheum (2006) 1.95
Rheumatology outcomes: the patient's perspective. J Rheumatol (2003) 1.87
Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol (2007) 1.87
Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Ann Rheum Dis (2012) 1.62
Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum (2005) 1.57
Patient initiated outpatient follow up in rheumatoid arthritis: six year randomised controlled trial. BMJ (2004) 1.52
Outcomes generated by patients with rheumatoid arthritis: how important are they? Musculoskeletal Care (2005) 1.46
Effects of ankle dorsiflexion range and pre-exercise calf muscle stretching on injury risk in Army recruits. Aust J Physiother (1998) 1.33
Patient perspective: reasons and methods for measuring fatigue in rheumatoid arthritis. J Rheumatol (2007) 1.32
Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Ann Rheum Dis (2012) 1.31
Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences. BMJ Open (2013) 1.17
MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda. J Rheumatol (2003) 1.05
Measuring fatigue in rheumatoid arthritis: a cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional questionnaire, visual analog scales, and numerical rating scales. Arthritis Care Res (Hoboken) (2010) 1.05
MCID/Low Disease Activity State Workshop: low disease activity state in rheumatoid arthritis. J Rheumatol (2003) 1.04
Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop. J Rheumatol (2014) 1.00
Fatigue in rheumatoid arthritis: time for a conceptual model. Rheumatology (Oxford) (2010) 0.99
Progress since OMERACT 6 on including patient perspective in rheumatoid arthritis outcome assessment. J Rheumatol (2005) 0.99
Collaboration with patients in the design of patient-reported outcome measures: capturing the experience of fatigue in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2010) 0.99
Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis. Rheumatology (Oxford) (2009) 0.98
Shifting normalities: interactions of changing conceptions of a normal life and the normalisation of symptoms in rheumatoid arthritis. Sociol Health Illn (2011) 0.96
It's like a juggling act: rheumatoid arthritis patient perspectives on daily life and flare while on current treatment regimes. Rheumatology (Oxford) (2013) 0.96
Updating the OMERACT filter: implications for patient-reported outcomes. J Rheumatol (2014) 0.92
The impact of patient-perceived restricted access to anti-TNF therapy for rheumatoid arthritis: a qualitative study. Musculoskeletal Care (2009) 0.92
Non-pharmacological interventions for fatigue in rheumatoid arthritis. Cochrane Database Syst Rev (2013) 0.91
Personal impact of disability in osteoarthritis: patient, professional and public values. Musculoskeletal Care (2006) 0.91
Patient involvement in outcome measures for psoriatic arthritis. Curr Rheumatol Rep (2014) 0.89
Utilizing qualitative data from nominal groups: exploring the influences on treatment outcome prioritization with rheumatoid arthritis patients. J Health Psychol (2011) 0.89
"If i wasn't this robust": patients' expectations and experiences at the Outcome Measures in Rheumatology Conference 2010. Patient (2013) 0.88
Patient-reported outcomes for arthritis: time to focus on personal life impact measures? Arthritis Rheum (2009) 0.88
Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Ann Rheum Dis (2011) 0.88
Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy. Ann N Y Acad Sci (2010) 0.86
Cognitive-behavioural approaches to self-management in rheumatic disease. Nat Rev Rheumatol (2012) 0.86
Ovarian cancer and ascites: A questionnaire on current management in the United kingdom. J Palliat Med (2006) 0.86
Self-efficacy as an appraisal that moderates the coping-emotion relationship: associations among people with rheumatoid arthritis. Psychol Health (2008) 0.85
Patient perspective: choosing or developing instruments. J Rheumatol (2011) 0.85
Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences--lessons learnt from a decade of collaboration in OMERACT: a qualitative study. BMJ Open (2013) 0.85
Rheumatology clinicians' experiences of brief training and implementation of skills to support patient self-management. BMC Musculoskelet Disord (2014) 0.84
Men's experiences of rheumatoid arthritis: an inductive thematic analysis. Musculoskeletal Care (2011) 0.83
Sensitivity to change of the Rheumatoid Arthritis Self-Efficacy scale (RASE) and predictors of change in self-efficacy. Musculoskeletal Care (2008) 0.83
Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9. J Rheumatol (2009) 0.82
Different wording of the Patient Global Visual Analogue Scale (PG-VAS) affects rheumatoid arthritis patients' scoring and the overall Disease Activity Score (DAS28): a cross-sectional study. Musculoskeletal Care (2013) 0.82
Fatigue in patients with rheumatoid arthritis: British and Dutch nurses' knowledge, attitudes and management. J Adv Nurs (2009) 0.82
Perimenopausal pneumococcal tubo-ovarian abscess--a case report and review. Infect Dis Obstet Gynecol (2004) 0.82
'It's more scary not to know': a qualitative study exploring the information needs of patients with systemic lupus erythematosus at the time of diagnosis. Musculoskeletal Care (2011) 0.81
What has been the effect on trial outcome assessments of a decade of patient participation in OMERACT? J Rheumatol (2013) 0.80
More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions. J Rheumatol (2015) 0.80
Clinical and psychological outcomes of patient education in rheumatoid arthritis. Musculoskeletal Care (2005) 0.80
A survey of psychological support provision for people with inflammatory arthritis in secondary care in England. Musculoskeletal Care (2014) 0.80
Updating the OMERACT filter: core areas as a basis for defining core outcome sets. J Rheumatol (2014) 0.79
Rheumatology telephone helplines: patient and health professionals' requirements. Musculoskeletal Care (2006) 0.79
Exploring the cultural validity of rheumatology outcomes. Br J Nurs (2012) 0.79
'To suddenly have a name for this thing… was wonderful': the patient's experience of receiving a diagnosis of systemic lupus erythematosus. Musculoskeletal Care (2012) 0.79
Updating the OMERACT filter: discrimination and feasibility. J Rheumatol (2014) 0.78
Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity. J Rheumatol (2014) 0.78
Evaluation of the Bristol Royal Infirmary physiotherapy programme for the management of patients with osteoarthritis of the knee. Musculoskeletal Care (2006) 0.78
Efficacy, safety and mechanism of action of modified-release prednisone in rheumatoid arthritis. Ther Adv Musculoskelet Dis (2012) 0.77
Fatigue is an independent outcome measure and is sensitive to change in patients with psoriatic arthritis. Clin Exp Rheumatol (2010) 0.77
Furthering our understanding of fatigue in rheumatoid arthritis. J Rheumatol (2012) 0.77
Updating the OMERACT filter: implications for imaging and soluble biomarkers. J Rheumatol (2014) 0.77
Transcutaneous electrical nerve stimulation as an adjunct to education and exercise for knee osteoarthritis: a randomized controlled trial. Arthritis Care Res (Hoboken) (2014) 0.76
Consent to research in arthritis: quantity of information versus quality. Arthritis Rheum (2003) 0.75
Measures of rheumatoid arthritis disease activity. J Rheumatol (2009) 0.75
A Q-methodology study of flare help-seeking behaviours and different experiences of daily life in rheumatoid arthritis. BMC Musculoskelet Disord (2014) 0.75
Biologic interventions for fatigue in rheumatoid arthritis. Cochrane Database Syst Rev (2016) 0.75
A Multicenter Nominal Group Study to Rank Outcomes Important to Patients, and Their Representation in Existing Composite Outcome Measures for Psoriatic Arthritis. J Rheumatol (2017) 0.75
Oestradiol and FSH in gestational trophoblastic disease: a prospective analysis of their predictive value. BJOG (2005) 0.75
Meeting the needs of children who have parents with chronic inflammatory musculoskeletal diseases. Rheumatology (Oxford) (2010) 0.75
Evaluation of the Personal Impact Health Assessment Questionnaire (PI HAQ) to capture the impact of disability in osteoarthritis. Musculoskeletal Care (2010) 0.75
Identifying Lynch Syndrome in Women Presenting With Endometrial Carcinoma Under the Age of 50 Years. Int J Gynecol Cancer (2017) 0.75
Piloting the new specialist training year 1 (ST1) interview process--using the OSCE. Med Teach (2007) 0.75
Assessing Estrogen-Induced Proliferative Response in an Endometrial Cancer Cell Line Using a Universally Applicable Methodological Guide. Int J Gynecol Cancer (2017) 0.75